Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-3,507
Closed -$292K – 239
2022
Q3
$292K Sell
3,507
-678
-16% -$58.3K 0.02% 191
2022
Q2
$334K Sell
4,185
-363
-8% -$35.2K 0.03% 187
2022
Q1
$473K Sell
4,548
-1,845
-29% -$153K 0.03% 166
2021
Q4
$481K Sell
6,393
-150
-2% -$10.5K 0.03% 170
2021
Q3
$424K Sell
6,543
-8
-0.1% -$489 0.03% 201
2021
Q2
$397K Hold
6,551
– – 0.03% 193
2021
Q1
$353K Hold
6,551
– – 0.03% 195
2020
Q4
$315K Sell
6,551
-134
-2% -$5.92K 0.03% 214
2020
Q3
$262K Sell
6,685
-186
-3% -$6.77K 0.03% 209
2020
Q2
$221K Sell
6,871
-737
-10% -$25.6K 0.02% 223
2020
Q1
$258K Sell
7,608
-340
-4% -$13.6K 0.03% 206
2019
Q4
$381K Buy
7,948
+8
+0.1% +$387 0.04% 203
2019
Q3
$396K Hold
7,940
– – 0.04% 197
2019
Q2
$424K Sell
7,940
-188
-2% -$9.82K 0.05% 190
2019
Q1
$429K Buy
8,128
+438
+6% +$22.8K 0.05% 191
2018
Q4
$361K Sell
7,690
-156
-2% -$8.14K 0.05% 201
2018
Q3
$453K Hold
7,846
– – 0.06% 200
2018
Q2
$427K Hold
7,846
– – 0.06% 201
2018
Q1
$371K Buy
+7,846
New +$393K 0.05% 216

Other funds holding NTR

BLB&B Advisors's NTR Position: Q4 2022 in Review

BLB&B Advisors sold out of Nutrien (NTR) in Q4 2022, closing a stake of 3,507 shares — an estimated $292K sold.

BLB&B Advisors first reported a position in NTR in Q1 2018 and held it in 19 quarters. The position peaked at $481K in Q4 2021. 695 funds tracked by Wall St. Rank hold NTR as of Q4 2022.

  • BLB&B Advisors reported no remaining Nutrien position as of Q4 2022 after selling out during the quarter.
  • BLB&B Advisors sold 3,507 Nutrien shares in Q4 2022, an estimated $292K.
  • BLB&B Advisors first reported a position in Nutrien in Q1 2018 and held it in 19 quarters.
  • BLB&B Advisors's Nutrien position peaked at $481K in Q4 2021.
  • 695 funds tracked by Wall St. Rank held Nutrien as of Q4 2022.

Based on BLB&B Advisors's 13F filing for Q4 2022, filed 18 Jan 2023.